PNPLA2 and metabolic dysfunction-associated steatotic liver disease: Therefore, we examined the physiological and pathophysiological effects in MASLD model after genetic and pharmacological manipulation of the Golgi PtdIns4P–CUL7FBXW8–ATGL axis.